Fisher LD - Search Results

1

Time-dependent covariates in the Cox proportional-hazards regression model.

Fisher LD, Lin DY. Fisher LD, et al. Annu Rev Public Health. 1999;20:145-57. doi: 10.1146/annurev.publhealth.20.1.145. Annu Rev Public Health. 1999. PMID: 10352854 Review.

2

Predictive value of pulmonary function tests before marrow transplantation.

Crawford SW, Fisher L. Crawford SW, et al. Chest. 1992 May;101(5):1257-64. doi: 10.1378/chest.101.5.1257. Chest. 1992. PMID: 1582281

3

Advances in clinical trials in the twentieth century.

Fisher LD. Fisher LD. Annu Rev Public Health. 1999;20:109-24. doi: 10.1146/annurev.publhealth.20.1.109. Annu Rev Public Health. 1999. PMID: 10352852 Review.

4

Mortality hazard functions as related to neutropenia at different times after marrow transplantation.

Offner F, Schoch G, Fisher LD, Torok-Storb B, Martin PJ. Offner F, et al. Among authors: fisher ld. Blood. 1996 Nov 15;88(10):4058-62. Blood. 1996. PMID: 8916974 Free article.

5

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.

Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders JE, et al. Anderson JE, et al. Among authors: fisher ld. J Clin Oncol. 1993 Dec;11(12):2342-50. doi: 10.1200/JCO.1993.11.12.2342. J Clin Oncol. 1993. PMID: 8246023

6

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Brown G, et al. Among authors: fisher ld. N Engl J Med. 1990 Nov 8;323(19):1289-98. doi: 10.1056/NEJM199011083231901. N Engl J Med. 1990. PMID: 2215615 Free article. Clinical Trial.

7

Carvedilol and the Food and Drug Administration approval process: an introduction.

Fisher LD, Moyé LA. Fisher LD, et al. Control Clin Trials. 1999 Feb;20(1):1-15. doi: 10.1016/s0197-2456(98)00052-x. Control Clin Trials. 1999. PMID: 10027497

8

Carvedilol and the Food and Drug Administration (FDA) approval process: the FDA paradigm and reflections on hypothesis testing.

Fisher LD. Fisher LD. Control Clin Trials. 1999 Feb;20(1):16-39. doi: 10.1016/s0197-2456(98)00054-3. Control Clin Trials. 1999. PMID: 10027498

9

Comments on Bayesian and frequentist analysis and interpretation of clinical trials.

Fisher LD. Fisher LD. Control Clin Trials. 1996 Oct;17(5):423-34. doi: 10.1016/s0197-2456(96)00043-8. Control Clin Trials. 1996. PMID: 8932975 No abstract available.

10

Statistical issues and analysis of mortality and morbidity randomized clinical trials in congestive heart failure.

Fisher LD. Fisher LD. J Card Fail. 1995 Sep;1(4):303-9. doi: 10.1016/1071-9164(95)90005-5. J Card Fail. 1995. PMID: 9420663 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results